Tyra Bioscience's market cap is currently $646.71M. The company's EPS TTM is $-1.606; its P/E ratio is ―; Tyra Bioscience is scheduled to report earnings on March 19, 2025, and the estimated EPS forecast is $-0.48. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Gross Profit	$ -353.00K	$ -296.00K	$ -140.00K	$ -47.00K	$ -8.00K
Operating Income	$ -79.94M	$ -58.93M	$ -26.29M	$ -9.30M	$ -3.12M
EBITDA	$ -79.59M	$ -58.63M	$ -26.15M	$ -9.25M	$ -3.11M
Net Income	$ -69.13M	$ -51.72M	$ -26.14M	$ -9.31M	$ -4.06M
Balance Sheet
Cash & Short-Term Investments	$ 203.47M	$ 251.21M	$ 302.18M	$ 15.22M	$ 108.00K
Total Assets	$ 225.86M	$ 266.18M	$ 306.70M	$ 16.01M	$ 528.00K
Total Debt	$ 6.50M	$ 2.62M	$ 1.18M	$ 142.00K	$ 253.00K
Net Debt	$ -51.51M	$ -248.59M	$ -301.00M	$ -15.08M	$ 145.00K
Total Liabilities	$ 21.59M	$ 8.35M	$ 4.96M	$ 29.65M	$ 5.27M
Stockholders' Equity	$ 204.26M	$ -95.70M	$ 301.74M	$ -13.64M	$ -4.74M
Cash Flow
Free Cash Flow	$ -50.91M	$ -50.84M	$ -24.41M	$ -8.07M	$ -2.64M
Operating Cash Flow	$ -50.14M	$ -50.28M	$ -23.75M	$ -7.76M	$ -2.62M
Investing Cash Flow	$ -144.60M	$ -559.00K	$ -645.00K	$ -312.00K	$ -20.00K
Financing Cash Flow	$ 1.54M	$ 632.00	$ 311.35M	$ 23.43M	$ 157.00K

Currency in USD

Tyra Bioscience Earnings and Revenue History

Income Statement >

Tyra Bioscience Debt to Assets

Balance Sheet >

Tyra Bioscience Cash Flow

Cash Flow >

Tyra Bioscience Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing